ImprimisRx CA, Inc recalls
ImprimisRx CA, Inc has 4 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 13 Sep 2017. The most frequent reason is labeling errors.
Total recalls4since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 13 Sep 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why imprimisrx ca, inc is recalled
Product types
By year
All imprimisrx ca, inc recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Curcumin Emulsion 10mg/ml Injection recalled by ImprimisRx CA, Inc | ImprimisRx CA, Inc | Labeling Errors | Nationwide |
| Drug | CLASS II | Timolol-Brimonidine-Dorzolamide-Latanoprost recalled | ImprimisRx CA, Inc | Labeling Errors | Nationwide |
| Drug | CLASS II | Timolol-Latanoprost PF Solution 5-0.005)%, Ophthalmic Drops recalled | ImprimisRx CA, Inc | Labeling Errors | Nationwide |
| Drug | CLASS II | Latanoprost PF Solution, 005%, Ophthalmic Drops in Sterile recalled | ImprimisRx CA, Inc | Labeling Errors | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.